Marimed director granted 173,077 RSUs, converts to shares

MARIMED INC. director Eva M.D.

Rhea-AI Filing Summary

MARIMED INC. director Eva M.D. Selhub received an equity award of 173,077 Restricted Stock Units on July 15, 2026 as part of her board fees. The RSUs vested immediately and converted one-for-one into 173,077 common shares, after which she directly owns 730,748 common shares.

Insider Trade Summary

173,077 shares exercised/converted

Exercise 3 txns

Insider Selhub Eva M.D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (RSU) F1, F2	173,077	$0.00	$0.00
Exercise	Restricted Stock Units (RSU) F1, F2	173,077	$0.00	$0.00
Exercise	Common stock F1	173,077	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units (RSU) — 0 contracts (Direct); Common stock — 730,748 shares (Direct)

Footnotes (2)

1. F1. RSUs convert to shares of common stock on a one-for-one basis.
2. F2. The RSUs were granted on July 15, 2026 and vested upon grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Accordingly, no RSUs remain outstanding under this award.

Key Figures

Common shares acquired: 173,077 shares RSUs granted and vested: 173,077 units Common shares owned after transaction: 730,748 shares +1 more

4 metrics

Common shares acquired 173,077 shares Shares of common stock received upon RSU conversion on July 15, 2026

RSUs granted and vested 173,077 units Restricted Stock Units granted and vested upon grant on July 15, 2026

Common shares owned after transaction 730,748 shares Direct MARIMED INC. common stock ownership after the July 15, 2026 award

Reported transaction price per share 0.0000 per share Per-share value field for the RSU grant and conversion transactions

Key Terms

Restricted Stock Units (RSU), derivative security, vested upon grant

3 terms

Restricted Stock Units (RSU) financial

"Transaction lists security title as Restricted Stock Units (RSU) convertible into common stock"

derivative security financial

"Transaction code M is described as Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vested upon grant financial

"The RSUs were granted on July 15, 2026 and vested upon grant"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MRMD director Eva M.D. Selhub report?

Eva M.D. Selhub reported an equity compensation transaction involving 173,077 Restricted Stock Units that converted into common shares. The RSUs vested immediately, resulting in her direct ownership of 730,748 MARIMED INC. common shares after the transaction.

How many MRMD common shares did Eva Selhub acquire in this Form 4 filing?

Eva Selhub acquired 173,077 MARIMED INC. common shares through the conversion of an equal number of RSUs. These RSUs were granted as part of her board fees and vested upon grant, increasing her direct common stock holdings to 730,748 shares.

Were the MRMD RSUs granted to Eva Selhub part of her board compensation?

Yes. The company states the RSUs were granted in lieu of cash for a portion of Eva Selhub’s board fees. This means she received equity instead of cash, with 173,077 RSUs vesting immediately and converting into the same number of common shares.

When did the RSU grant for MRMD director Eva Selhub vest and convert?

The RSUs granted to Eva Selhub on July 15, 2026 vested upon grant and converted on a one-for-one basis into common shares. According to the footnotes, no RSUs remain outstanding under this specific award after the conversion.

How many MRMD shares does Eva Selhub own after the reported transactions?

After the reported RSU grant and conversion, Eva Selhub directly owns 730,748 MARIMED INC. common shares. This reflects the addition of 173,077 shares received from the immediate vesting and one-for-one conversion of her Restricted Stock Units.

Did the MRMD Form 4 indicate any sales or gifts by Eva Selhub?

No sales or gifts were reported for Eva Selhub. The Form 4 shows RSUs being granted and then converted into 173,077 common shares, with no sale transactions, gifts, or tax-withholding dispositions disclosed in connection with this equity award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/17/2026 - 04:12 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Selhub Eva M.D.

(Last) (First) (Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD MASSACHUSETTS 02062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	07/15/2026		M		173,077	A	$0(1)	730,748	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSU)	(1)	07/15/2026		A		173,077		(2)	(2)	Common Stock, par value $.001 per share	173,077	$0	173,077	D
Restricted Stock Units (RSU)	(1)	07/15/2026		M			173,077	(2)	(2)	Common Stock, par value $.001 per share	173,077	$0	0	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. The RSUs were granted on July 15, 2026 and vested upon grant in accordance with the terms of the award agreement between the Issuer and the Reporting Person. Accordingly, no RSUs remain outstanding under this award.

Remarks:

The RSUs were granted in lieu of cash as payment for a portion of the Reporting Person's fees for serving on the Issuer's Board of Directors.

	/s/ Eva Selhub	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)